MMP11 and ovarian endometrioid adenocarcinoma: In this context, MMP-7, MMP-10, MMP-11, and MMP-26 demonstrated promising diagnostic profiles in our cohort, suggesting that, rather than replacing established markers, they may serve as valuable complementary tools to improve diagnostic precision, especially in endometrioid ovarian cancer, and as markers in the differentiation of benign from malignant lesions.